Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients.

MLA

Saito, Jumpei, et al. “Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients.” Antimicrobial Agents and Chemotherapy, vol. 65, no. 2, Jan. 2021. EBSCOhost, https://doi.org/10.1128/AAC.01909-20.

APA

Saito, J., Shoji, K., Oho, Y., Kato, H., Matsumoto, S., Aoki, S., Nakamura, H., Ogawa, T., Hasegawa, M., Yamatani, A., & Miyairi, I. (2021). Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients. Antimicrobial Agents and Chemotherapy, 65(2). https://doi.org/10.1128/AAC.01909-20

Chicago

Saito, Jumpei, Kensuke Shoji, Yusuke Oho, Hiroki Kato, Shotaro Matsumoto, Satoshi Aoki, Hidefumi Nakamura, et al. 2021. “Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients.” Antimicrobial Agents and Chemotherapy 65 (2). doi:10.1128/AAC.01909-20.